Medicina, Dermatología y Toxicología
Departamento
Hospital Infanta Leonor
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Infanta Leonor (98)
2024
-
Comparative Study of the Effectiveness of Vedolizumab Versus Ustekinumab After Anti-TNF Failure in Crohn's Disease (Versus-CD): Data from the ENEIDA Registry
Journal of Crohn's & colitis, Vol. 18, Núm. 1, pp. 65-74
-
Differences in the clinical and hormonal presentation of patients with familial and sporadic primary aldosteronism
Frontiers in Endocrinology, Vol. 15
-
Epidemiology of fungal infection in COVID 19 in Spain during 2020 and 2021: a nationwide study
Scientific Reports, Vol. 14, Núm. 1
-
Executive summary of the consensus document for the training and development of clinical ultrasound in internal medicine: Recommendations from the Clinical Ultrasound Working Group of the Spanish Society of Internal Medicine (GTECO-SEMI)
Revista Clinica Espanola, Vol. 224, Núm. 1, pp. 57-63
-
Is adrenal venous sampling always necessary to differentiate between unilateral and bilateral primary aldosteronism? Lesson from the SPAIN-ALDO register
Endocrine, Vol. 84, Núm. 2, pp. 683-693
-
Multidisciplinary Delphi consensus on challenges and key factors for an optimal care model in chronic kidney disease
Nefrologia
-
Real-life data of immune recovery using bictegravir/emtricitabine/ tenofovir alafenamide in virologically suppressed people living with HIV. Results at 48–96 weeks of RETROBIC Study
Journal of Antimicrobial Chemotherapy, Vol. 79, Núm. 3, pp. 595-607
-
Renin as a Biomarker to Guide Medical Treatment in Primary Aldosteronism Patients. Findings from the SPAIN-ALDO Registry
High Blood Pressure and Cardiovascular Prevention, Vol. 31, Núm. 1, pp. 43-53
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Autonomous cortisol secretion in patients with primary aldosteronism: prevalence and implications on cardiometabolic profile and on surgical outcomes
Endocrine Connections, Vol. 12, Núm. 9
-
Cardiogenic shock code 2023. Expert document for a multidisciplinary organization that allows quality care
Revista Espanola de Cardiologia, Vol. 76, Núm. 4, pp. 261-269
-
Dolutegravir Plus 3TC in Virologically Suppressed PLWHIV: Immunological Outcomes in a Multicenter Retrospective Cohort in Spain during the COVID-19 Pandemic
Viruses, Vol. 15, Núm. 2
-
Effect of viral storm in patients admitted to intensive care units with severe COVID-19 in Spain: a multicentre, prospective, cohort study
The Lancet Microbe, Vol. 4, Núm. 6, pp. e431-e441
-
Efficacy and Safety of Two-Drug Regimens with Dolutegravir plus Rilpivirine or Lamivudine in HIV-1 Virologically Suppressed People Living with HIV
Viruses, Vol. 15, Núm. 4
-
Epidemiology of Fabry disease in patients in hemodialysis in the Madrid community
Nefrologia, Vol. 43, Núm. 4, pp. 435-441
-
Epidemiology of bacterial co-infections and risk factors in COVID-19-hospitalized patients in Spain: a nationwide study
European journal of public health, Vol. 33, Núm. 4, pp. 675-681
-
Impact of congestion and perfusion status in the emergency department on severity of decompensation and short-term prognosis in patients with acute heart failure
European Heart Journal: Acute Cardiovascular Care, Vol. 12, Núm. 3, pp. 165-174
-
Influence of non-osteoporotic treatments in patients on active anti-osteoporotic therapy: evidence from the OSTEOMED registry
European Journal of Clinical Pharmacology, Vol. 79, Núm. 10, pp. 1333-1339
-
Key Factors Associated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19 Patients
Archivos de Bronconeumologia, Vol. 59, Núm. 4, pp. 205-215
-
Predict the Effects of Dolutegravir (DTG) Plus Lamivudine (3TC) on Immunological Responses in People Living with HIV (PLWHIV)
Journal of Clinical Medicine, Vol. 12, Núm. 3